|Bid||97.49 x 800|
|Ask||97.63 x 800|
|Day's Range||94.20 - 98.17|
|52 Week Range||68.30 - 102.96|
|Beta (5Y Monthly)||0.98|
|PE Ratio (TTM)||16.04|
|Earnings Date||Jul 19, 2021 - Jul 23, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||115.00|
At this time, I'd like to turn the conference over to Mr. Patrique Richards, Executive Director of Investor Relations and Business Development. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company.
USANA Health (USNA) delivered earnings and revenue surprises of -7.64% and 2.52%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 3, 2021.